Sanofi SA vs Williams-Sonoma, Inc. — how do they compare? Sanofi SA trades at $44.05 (market cap $104.83B), while Williams-Sonoma, Inc. trades at $223.2 (market cap $26.30B). The key difference: Sanofi SA is far larger — about 4× Williams-Sonoma, Inc.'s market cap, and Sanofi SA pays the higher dividend (5.5%). Which is the better fit depends on your goals.
| SNY | WSM | |
|---|---|---|
Market Cap | $104.83B | $26.30B |
Sector | Health | Consumer Cyclical |
52-Week High | $52.34 | $240.06 |
52-Week Low | $41.33 | $168.64 |
Enterprise Value | $121.32B | $27.14B |
Dividend Yield | 5.5% | 1.36% |
Trailing returns across standard periods
Latest headlines on both assets
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →With a wide retail and direct-to-consumer presence, Williams-Sonoma is a leader in the $300 billion domestic home category, focused on expanding its exposure in the B2B, marketplace, and franchise areas. Namesake Williams-Sonoma (175 stores) offers high-end cooking essentials, while Pottery Barn (189) provides casual home accessories. Brand extensions include Pottery Barn Kids (52) and PBteen. West Elm (121) is an emerging concept for young professionals, and Rejuvenation (9) offers lighting and house parts. Williams-Sonoma also has a business-to-business team that supports projects that range from residential to large-scale commercial.
Read more on WSM →